ViaLase
ViaLase, Inc. is a clinical-stage medical technology company developing a noninvasive femtosecond laser treatment for glaucoma. Their ViaLase Laser aims to improve the current treatment paradigm by offering enhanced precision and visibility during trabecular meshwork procedures. This innovative approach has the potential to elevate the standard of care for glaucoma patients.
Funding Round: Series C
Funding Amount: $40M
Date: 01-Apr-2024
Investors: Venture Investors Health Fund, Arboretum Ventures, Falcon Vision, KKR
Markets: Medical Technology, Ophthalmology, Health Care, Medical Device, Wellness
HQ: Corona Del Mar, California, United States
Founded: 2019
Website: https://www.vialase.com/
LinkedIn: https://www.linkedin.com/company/vialase
Crunchbase: https://www.crunchbase.com/organization/vialase
Leave a Comment
Comments
No comments yet.